Biological Therapy in Treating Patients With Metastatic Cancer

Completed · Phase 2

Conditions studied: Kidney Cancer, Melanoma (Skin), Unspecified Adult Solid Tumor, Protocol Specific

In brief

RATIONALE: Biological therapies use different ways to stimulate the immune system and stop cancer cells from growing. Combining different types of biological therapies, including interferon alfa, interleukin-2, and tumor infiltrating lymphocytes, may kill more cancer cells. PURPOSE: Phase II trial to study the effectiveness of biological therapies, including interferon alfa, interleukin-2, and tumor infiltrating lymphocytes, in treating patients with metastatic cancer.

Key facts

Study ID
NCT00002733
Run by
Hoag Memorial Hospital Presbyterian
People needed
30
Starts
1996-01-01
Expected to finish
2000-01-01
Last updated by the study team
2011-05-11

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.